eEF1A1基因克隆、原核分泌表达及融合蛋白纯化

eEF1A1作为蛋白合成中的重要翻译延伸因子,可与多种功能性蛋白如F-actin、BPOZ-2结合,并在细胞凋亡、蛋白降解方面起重要作用.以往原核基因工程蛋白表达系统大多为包涵体表达的变性分子,需要复性.为了获得eEF1A1原核分泌性可溶性蛋白分子,克隆了人eEF1A1蛋白编码序列(约1 300 bp),并成功构建pET22b-A原核分泌表达重组质粒,转化到大肠杆菌BL21(DE3)菌株,0.4 mmol/L终浓度IPTG诱导,经不同温度下包涵体与胞浆蛋白组分分析,快速明确蛋白表达情况,即诱导4 h后,37℃表达于包涵体组分,在30℃分泌表达至胞浆组分.通过His-Trap亲和层析纯化柱进行线性洗脱,Bradford法测定蛋白浓度高达620 mg/mL,SDS-PAGE分析纯度约为95%,蛋白大小符合50 kD,Western blotting显示目的蛋白能被eEF1A1抗体识别;质谱分析证实重组蛋白为人eEF1A1蛋白分子.为进一步研究其与重要功能性蛋白的相互作用及在细胞凋亡和蛋白降解中的作用奠定基础.     

eEF1A1通过HGF/c-MET通路调控肝癌细胞的迁移和侵袭能力

目的 探讨真核翻译延长因子1A1(eukaryotic translation elongation factor 1 α 1,eEF1A1)对肝癌细胞的侵袭、迁移和HGF/c-MET通路的影响及作用机制。方法 采用qRT-PCR和Western bolt检测肝癌细胞和组织中eEF1A1表达。构建eEF1A1敲除载体转染HLF和Alex肝癌细胞,CCK-8和Transwell实验检测细胞的增殖、侵袭和迁移能力。KM plotter分析患者的总体预后。通过eEF1A1基因敲除的转录组测序,Western bolt检测HGF、c-MET和p-c-MET蛋白的表达。裸鼠皮下成瘤实验检测eEF1A1对肝癌肿瘤的影响。结果 eEF1A1在肝癌细胞和组织中显著升高,敲低eEF1A1能抑制HCC细胞的增殖、迁移和侵袭。eEF1A1高表达与肝癌的不良预后相关。此外,敲除eEF1A1显著降低HGF和p-c-MET蛋白水平,抑制肝癌肿瘤的生长,但c-MET蛋白水平无显著差异。结论 eEF1A1通过抑制HGF/c-MET信号通路抑制肝癌细胞迁移和侵袭。     

Palmdelphin在出生后发育的大鼠小脑中的表达模式研究

Palmdelphin是参与质膜的动态变化与细胞形态的调控的paralemmin家族新成员,与神经发育的相关性尚不明确.前期工作提示,它与调控小脑发育的一种肌动蛋白结合蛋白Mtss1(metastasis suppressor1)具有一定相关性.为了探索该基因与小脑出生后发育的相关性,利用原位杂交技术研究Palmdelphin在小脑中的时空表达,结果表明,Palmdelphin在出生后第7d大鼠小脑中有明显的表达,且分布主要集中在浦肯野神经元.半定量RT-PCR的结果进一步表明Palmdelphin的转录水平在小脑发育过程中受到调控,在出生后7d有表达高峰.这些结果显示Palmdelphin与小脑出生后神经元发育存在一定相关性.     

Bmal1对小鼠胚胎期皮层神经元放射状迁移和轴突投射的影响

大脑皮层的发育是脑结构形成与功能建立的重要基础,在此过程中,皮层神经元放射状迁移及胼胝体区的轴突投射是必不可少的关键环节,该环节受基因转录的调控,但相关的分子机制目前仍不明确。转录因子BMAL1 (brain and muscle Arnt-like protein1)是体内重要的生物钟节律因子之一,最新研究发现其还参与调节海马神经祖细胞增殖,提示其与神经发育存在潜在的相关性。为明确Bmal1基因在大脑皮层发育中的具体作用,本研究首先通过RT-PCR和Real-timePCR检测Bmal1基因在神经系统中的表达情况。结果表明,Bmal1基因在神经系统中表达丰富,并且在发育期的大脑内呈现特定的表达规律:在胚胎后期和出生后早期脑内表达水平相对较高,以出生后第3 d为高峰。进一步通过联合使用小鼠子宫内胚胎电转和RNAi干扰方法敲减脑内神经元中Bmal1的表达水平,结果发现胚胎期皮层神经元的放射状迁移发生了延迟,延迟程度与RNAi的敲减效率呈正相关,存在一定的基因剂量-效应关系。进一步观察发现,在胚胎期脑内神经元中降低Bmal1表达水平以后,胼胝体轴突向对侧大脑半球的投射也出现了明显的缺陷。上述研究结果表明,BMAL1是大脑皮层神经元的放射状迁移以及轴突投射发育过程中的一个重要的调控分子,为从转录因子角度深入理解大脑皮层发育的分子调节机制和寻找调控靶点提供了新的线索。     

GSK3β/eEF2K信号通路对小鼠肺纤维化过程的影响*

目的: 探讨糖原合成酶激酶-3(GSK3β)/真核延伸因子激酶2(eEF2K)信号通路对肺纤维化进程的影响,为临床治疗肺纤维化寻找新的思路。方法: 采用一次性气管注射法构建C57BL/6雄性小鼠博莱霉素肺纤维化模型,造模14 d后将动物分成模型组、阴性抑制组与抑制组(n=5),另设空白组不作处理。抑制组使用腹腔注射TDZD-8(4 mg/kg),阴性抑制组腹腔注射二甲基亚砜(DMSO)溶液,28 d后处死采集指标。采用苏木精-伊红染色法检测小鼠肺脏病变情况;试剂盒水解法检测肺组织中羟脯氨酸(Hyp)的含量;采用Western blot法检测肺脏中GSK3β、磷酸化GSK3β(p-GSK3β)、eEF2K、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、基质金属蛋白酶-2前体蛋白(pro-MMP-2)、基质金属蛋白酶-2(MMP-2)蛋白表达水平,使用免疫组织化学法检测肺脏中MMP-2、胶原蛋白I(Col I)、胶原蛋白Ⅲ(Col Ⅲ)、α-平滑肌蛋白(α-SMA)的表达。结果: 与空白组相比,模型组中GSK3β、p-GSK3β、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、pro-MMP-2、MMP-2、Col I、Col Ⅲ、α-SMA蛋白表达水平升高,eEF2K蛋白表达水平降低(P＜0.05);与模型组相比,抑制组GSK3β、p-GSK3β、p-eEF2K(Ser70)、p-eEF2K(Ser392)、p-eEF2K(Ser470)、pro-MMP-2、MMP-2、Col I、Col Ⅲ、α-SMA蛋白表达降低,eEF2K蛋白表达升高(P＜ 0.05)。结论: GSK3β能通过Ser70、Ser392、Ser470这3个位点磷酸化激活eEF2K,增加纤维化指标含量,促进肺纤维化形成,加重肺组织病变。     

促甲状腺激素释放激素受体-1(TRH-R1)蛋白在大鼠出生后睾丸不同发育阶段的表达和定位

目的研究促甲状腺激素释放激素受体-1(thyrotrophin-releasing hormone receptor type-1, TRH-R1)在大鼠睾丸出生后不同发育阶段的表达,探讨其在生殖发育调节中的作用.方法应用蛋白质免疫印迹杂交技术以及免疫组织化学ABC法检测TRH-R1在8d、15d、20d、35d、60d和90d大鼠睾丸中的表达和定位,并结合图像分析技术对免疫组化结果进行统计学分析观察其在发育过程中的变化.结果免疫印迹杂交发现TRH-R1蛋白表达于15d以后各阶段的大鼠睾丸;而运用免疫组化在第8d即检测到TRH-R1的表达,以后发育过程中的各个阶段均有阳性反应细胞, TRH-R1定位于大鼠睾丸的间质细胞;免疫反应阳性物均位于胞膜和胞质,胞核区为阴性;图像分析结果表明,随着大鼠睾丸的发育,TRH-R1表达量呈增多趋势,且具有统计学差异(P＜0.01).结论本实验证明TRH-R1在出生后8d大鼠的睾丸内即有表达,并持续表达于其后各个发育阶段;TRH-R1定位于睾丸的间质细胞,其表达量随着增龄变化呈增多趋势,即同发育过程相关.     

Mtss1抗体制备及小脑中不同亚型磷酸化水平的检测

肿瘤转移抑制蛋白(Metastasis suppressor1,Mtss1),又名肿瘤转移消失蛋白(Missing in metastasis,MIM)在小脑神经元发育中受到调控,依次表达两种亚型:包含Src磷酸化位点的广泛表达亚型;含Src磷酸化位点片段经RNA剪接去除的神经元特异亚型.为检测这两种Mtss1亚型的酪氨酸磷酸化水平是否因Src磷酸化位点的去除存在明显区别,制备了灵敏度较高并可特异性沉淀外源和内源表达的Mtss1的兔多克隆抗体,对发育时期与成年大鼠小脑内源Mtss1酪氨酸磷酸化水平进行检测,发现成年后的Mtss1与出生后发育时期的Mtss1均发生明显的酪氨酸磷酸化,表明剪接去除包含有Src磷酸化位点中的神经元特异亚型中,还有其他的酪氨酸残基被磷酸化,提示其他酪氨酸磷酸化激酶信号通路对Mtss1神经元亚型的调控作用.     

Atg5在肌萎缩侧索硬化症转基因小鼠纹状体和脑干中表达降低

目的研究自噬相关基因Atg5在肌萎缩侧索硬化症(ALS)转基因小鼠纹状体和脑干中的表达情况,探讨Atg5与ALS发病的关系。方法分别取ALS转基因小鼠和同窝野生型小鼠95d、108d和122d的纹状体和脑干,应用免疫荧光技术检测Atg5在纹状体和脑干中的表达及与神经元的共定位关系,应用q RT-PCR技术检测Atg5 m RNA表达情况,应用Western blot技术检测蛋白表达的改变。结果免疫荧光双标染色检测发现,ALS转基因小鼠和野生型小鼠纹状体和脑干中Atg5阳性细胞与β-tubulinⅢ标记的神经元共表达;与野生型小鼠比较,ALS转基因小鼠纹状体和脑干内舌下神经核和面神经核中Atg5免疫反应性降低;q RT-PCR分析显示,ALS转基因小鼠纹状体内Atg5 m RNA表达水平在95d、108d和122d时均显著低于同窝野生型小鼠纹状体内Atg5 m RNA表达水平;脑干内Atg5 m RNA表达水平在108d和122d时均显著低于同窝野生型小鼠脑干内Atg5 m RNA表达水平;Western bot分析显示,与野生型小鼠比较,ALS转基因小鼠纹状体和脑干内Atg5蛋白表达水平在108d和122d时显著降低。结论 ALS转基因小鼠纹状体和脑干中Atg5的表达降低,提示Atg5调控的自噬改变与ALS发病关系密切。     

SRG4在出生后小鼠睾丸及隐睾中的表达特性

研究小鼠生精新基因SRG4在出生后小鼠睾丸及手术隐睾中的表达特性, 为了解SRG4在精子发生中的作用奠定基础。取出生后1, 3, 12 w小鼠睾丸进行免疫组化检测, 观察SRG4蛋白在出生后小鼠不同发育阶段睾丸中的表达; 制备单侧手术隐睾模型, 取术后0~18 d 的隐睾组织进行半定量RT-PCR检测, 观察SRG4 mRNA在隐睾病变过程中的表达变化, 并对隐睾术后18 d 睾丸进行组织原位杂交分析。免疫组化分析结果表明, SRG4蛋白在出生1 w的小鼠睾丸中几乎检测不到, 在出生3 w的小鼠睾丸中有明显表达, 在出生12 w的小鼠中大量表达, 主要分布在精母细胞和圆形精子细胞胞浆及胞膜, 呈不均匀分布。半定量RT-PCR结果发现, SRG4 mRNA在小鼠隐睾术后0~6 d表达没有明显下调, 9 d 开始表达下调, 第18 d表达最低。组织原位杂交结果表明, 术后18 d隐睾睾丸生殖细胞大量凋亡, 精曲小管中仅见到个别的SRG4阳性信号, 而对照则不受影响。上述结果说明, SRG4蛋白表达受小鼠生长发育调控; 隐睾模型中, 随着生殖细胞的大量凋亡, SRG4基因表达下调, 提示SRG4基因可作为一个精子发生特定阶段的分子标记用以研究精子发生过程。     

Tbx18通过下调EMT信号分子参与调控心脏发育

转录因子Tbx18(Tbx18)在小鼠胚胎心外膜上皮细胞表达并调控心外膜上皮细胞向心系细胞分化.上皮间充质转化(EMT)过程是器官发育和形成的重要机制.为阐述Tbx18通过调控下游EMT关键信号分子参与心外膜上皮细胞分化和心脏发育,本研究运用Tbx18-Cre/Rosa26R-EYFP双杂合基因敲入小鼠和免疫荧光共聚焦,证实Tbx18+心系细胞和EMT关键信号分子Snail1、Smad、Slug、Twist在发育后期胚鼠心外膜和心外膜下间充质发生共聚焦.同时还发现,Tbx18在胚鼠不同发育阶段的表达模式和Tbx18+心系细胞内上述EMT关键信号分子的表达模式相似.Tbx18和EMT关键信号分子在发育心脏存在相似的时空表达模式,因此,它们之间可能存在相互调控作用.运用Tbx18突变技术揭示了Tbx18突变型胚鼠心脏EMT关键信号分子表达水平均较野生型显著下调,直接证实了上述4个EMT信号分子是Tbx18的可能靶点.理解Tbx18参与心脏发育的下游靶点有助于改善成年心脏损伤后的再生修复.     

衰老细胞中热休克转录因子1的异常调节和定位

为评估人热休克转录因子1（HSF1）在衰老细胞中呈现年龄依赖功能失调机制, 通过凝胶电泳迁移率改变实验(EMSA)和RNA酶保护实验等了解低总体倍增水平（PDLs）的年轻和高PDLs的衰老IMR90双倍体人肺纤维母细胞的HSF1 DNA 结合活性、HSF1蛋白质及其编码转录子mRNA水平和亚细胞分布.使用H2O2诱导年轻IMR90细胞成为“应激诱导早熟性老化(SIPS)” 细胞,并与复制性衰老细胞比较HSF1 DNA 结合活性、HSF1亚细胞分布和细胞内过氧化物含量.在不同年龄的IMR90细胞中,无论体内或体外,HSF1激活能力与细胞年龄呈反相关,但细胞内HSF1蛋白质与其mRNA水平并无改变.HSF1的亚细胞定位分析显示,HSF1主要存在于年轻细胞胞质中,热刺激促使三体形成和核转移;而在衰老细胞中,37℃时HSF1大部分存在于细胞核内,热刺激后形成三体,与DNA结合能力明显比年轻细胞弱;用H2O2诱导的应激成熟前老化细胞内,HSF1功能和亚细胞分布都与复制性衰老细胞相似.结果显示,细胞年龄与HSF1的激活和定位相关,而与HSF1含量无关,这些变化可能是通过氧化修饰所致.     

Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice

The eEF1Alpha-2 gene (S1) encodes a tissue-specific isoform of peptide elongation factor-1A (eEF1A-1); its mRNA is expressed only in brain, heart, and skeletal muscle, tissues dominated by terminally differentiated, long-lived cells. Homozygous mutant mice exhibit muscle wasting and neurodegeneration, resulting in death around postnatal day 28. eEF1Alpha-2/S1 protein shares 92% identity with eEF1A-1; because specific antibodies for each were not available previously, it was difficult to study the developmental expression patterns of these two peptide elongation factors 1A in wasted and wild-type mice. We generated a peptide-derived antiserum that recognizes the eEF1Alpha-2/S1 isoform and does not cross-react with eEF1A-1. We characterized the expression profiles of eEF1A-1 and eEF1A-2/S1 during development in wild-type (+/+), heterozygous (+/wst), and homozygous (wst/wst) mice. In wild-type and heterozygous animals, eEF1A-2/S1 protein is present only in brain, heart, and muscle; the onset of its expression coincides with a concomitant decrease in the eEF1A-1 protein level. In wasted mutant tissues, even though eEF1A-2/S1 protein is absent, the scheduled decline of eEF1A-1 occurs nonetheless during postnatal development, as it does in wild-type counterparts. In the brain of adult wild-type mice, the eEF1A-2/S1 isoform is localized in neurons, whereas eEF1A-1 is found in non-neuronal cells. In neurons prior to postnatal day 7, eEF1A-1 is the major isoform, but it is later replaced by eEF1A-2/S1, which by postnatal day 14 is the only isoform present. The postdevelopmental appearance of eEF1A-2/S1 protein and the decline in eEF1A-1 expression in brain, heart, and muscle suggest that eEF1A-2/S1 is the adult form of peptide elongation factor, whereas its sister is the embryonic isoform, in these tissues. The absence of eEF1A-2/S1, as well as the on-schedule development-dependent disappearance of its sister gene, eEF1A, in wst/wst mice may result in loss of protein synthesis ability, which may account for the numerous defects and ultimate fatality seen in these mice.     

Nerve growth factor specifically stimulates translation of eukaryotic elongation factor 1A-1 (eEF1A-1) mRNA by recruitment to polyribosomes in PC12 cells

During postnatal brain development the level of peptide elongation factor-1A (eEF1A-1) expression declines and that of the highly homologous isoform, eEF1A-2, increases in neurons. eEF1A-1 is implicated in cytoskeletal interactions, tumorigenesis, differentiation, and the absence of eEF1A-2 is implicated in neurodegeneration in the mouse mutant, wasted. The translation of eEF1A-1 mRNA is up-regulated via mitogenic stimulation. However, it is not known if eEF1A-1 mRNA translation is regulated by neurotrophins or if its synthesis is differentially regulated than that of the neuronal isoform, eEF1A-2. Regulated translation of these factors by neurotrophins, particularly by the Trk class of neurotrophin receptors, would implicate them in differentiation, survival, and neuronal plasticity. In this study, we investigated the effect of nerve growth factor (NGF) stimulation on the synthesis of eEF1A-1 and eEF1A-2. We found that NGF stimulation causes a preferential synthesis of eEF1A-1 over eEF1A-2 in PC12 cells. We analyzed the co-sedimentation of eEF1A-1 mRNA with polyribosome fractions in sucrose gradients, and found that NGF stimulation enriched the presence of eEF1A-1 mRNA in polyribosomes, indicating that the translation of eEF1A-1 mRNA is regulated by NGF. Inhibitors of phosphatidylinositol 3-kinase (LY 294002), mammalian target of rapamycin (rapamycin), and the NGF receptor, TrkA (K-252a), but not of mitogen-activated protein kinase (PD 98059), prevented the recruitment of eEF1A-1 mRNA to polyribosomes. The mobilization of eEF1A-1 mRNA to polyribosomes was rapamycin-sensitive in both proliferating and differentiated PC12 cells, indicating the importance of this pathway during differentiation. Our data shows that after growth factor withdrawal, an NGF-signaling pathway stimulates eEF1A-1 mRNA translation in proliferating and differentiated PC12 cells. Therefore, eEF1A-1 mRNA is a specific translational target of TrkA signaling.     

Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress

eEF1A-1 and eEF1A-2 are two isoforms of translation elongation factor eEF1A. In adult mammalian tissues, isoform eEF1A-1 is present in all tissues except neurons, cardiomyocytes, and myotubes, where its isoform, eEF1A-2, is the only form expressed. Both forms of eEF1A have been characterized to function in the protein elongation step of translation, and eEF1A-1 is shown to possess additional non-canonical roles in actin binding/bundling, microtubule bundling/severing, and cellular transformation processes. To study whether eEF1A-2 has similar non-canonical functions, we carried out a yeast two-hybrid screening using a full sequence of mouse eEF1A-2 as bait. A total of 78 hits, representing 23 proteins, were identified and validated to be true positives. We have focused on the protein with the highest frequency of hits, peroxiredoxin I (Prdx-I), for in-depth study of its functional implication for eEF1A-2. Here we show that Prdx-I coimmunoprecipitates with eEF1A-2 from extracts of both cultured cells and mouse tissues expressing this protein, but it does not do so with its isoform, eEF1A-1, even though the latter is abundantly present. We also report that an eEF1A-2 and Prdx-I double transfectant increases resistance to peroxide-induced cell death as high as 1 mM peroxide treatment, significantly higher than do single transfectants with either gene alone; this protection is correlated with reduced activation of caspases 3 and 8, and with increased expression of pro-survival factor Akt. Thus, our results suggest that eEF1A-2 interacts with Prdx-I to functionally provide cells with extraordinary resistance to oxidative stress-induced cell death.     

Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis.

Peptide elongation factor eEF1A-2/S1, which shares 92% homology with eEF1A-1/EF-1alpha, is exclusively expressed in brain, heart, and skeletal muscle. In these tissues, eEF1A-2/S1 is the only type 1A elongation factor expressed in adulthood because a transition from eEF1A-1/EF-1alpha to eEF1A-2/S1 occurs in early postnatal development. In this article, we report that the expression of eEF1A-2/S1 protein is activated upon myogenic differentiation. Furthermore, we show that upon serum deprivation-induced apoptosis, eEF1A-2/S1 protein disappears and is replaced by its homolog eEF1A-1/EF-1alpha in dying myotubes; cell death is characterized by the activation of caspase-3. In addition, we show that the continuous expression of eEF1A-2/S1 resulting from adenoviral gene transfer protects differentiated myotubes from apoptosis by delaying their death, thus suggesting a prosurvival function for eEF1A-2/S1 in skeletal muscle. In contrast, myotube death is accelerated by the introduction of the homologous gene, eEF1A-1/EF-1alpha, whereas cells transfected with antisense eEF1A-1/EF-1alpha are protected from apoptosis. These results demonstrate that the two sister genes, eEF1A-1/EF-1alpha and eEF1A-2/S1, regulate myotube survival with the former exerting prodeath activity and the latter a prosurvival effect.     

Translation elongation factor-1A1 (eEF1A1) localizes to the spine by domain III

In vertebrates, there are two variants of eukaryotic peptide elongation factor 1A (eEF1A; formerly eEF-1α), eEF1A1 and eEF1A2, which have three well-conserved domains (D(I), D(II), and D(III)). In neurons, eEF1A1 is the embryonic type, which is expressed during embryonic development as well as the first two postnatal weeks. In the present study, EGFP-tagged eEF1A1 truncates were expressed in cortical neurons isolated from rat embryo (E18-19). Live cell images of transfected neurons showed that D(III)-containing EGFP-fusion proteins (EGFP-D(III), -D(II)-III, -D(I)-III) formed clusters that were confined within somatodendritic domains, while D(III)-missing ones (EGFP-D(I), -D(II), -D(I)-II) and control EGFP were homogeneously D(I)spersed throughout the neuron incluD(I)ng axons. In dendrites, EGFP-D(III) was targeted to the heads of spine- and filopoD(I)a-like protrusions, where it was colocalized with SynGAPα, a postsynaptic marker. Our data inD(I)cate that D(III) of eEF1A1 meD(I)ates formation of clusters and localization to spines.     

Characterisation of Translation Elongation Factor eEF1B Subunit Expression in Mammalian Cells and Tissues and Co-Localisation with eEF1A2

Translation elongation is the stage of protein synthesis in which the translation factor eEF1A plays a pivotal role that is dependent on GTP exchange. In vertebrates, eEF1A can exist as two separately encoded tissue-specific isoforms, eEF1A1, which is almost ubiquitously expressed, and eEF1A2, which is confined to neurons and muscle. The GTP exchange factor for eEF1A1 is a complex called eEF1B made up of subunits eEF1Bα, eEF1Bδ and eEF1Bγ. Previous studies have cast doubt on the ability of eEF1B to interact with eEF1A2, suggesting that this isoform might use a different GTP exchange factor. We show that eEF1B subunits are all widely expressed to varying degrees in different cell lines and tissues, and at different stages of development. We show that ablation of any of the subunits in human cell lines has a small but significant impact on cell viability and cycling. Finally, we show that both eEF1A1 and eEF1A2 colocalise with all eEF1B subunits, in such close proximity that they are highly likely to be in a complex.     

Haploinsufficiency for Translation Elongation Factor eEF1A2 in Aged Mouse Muscle and Neurons Is Compatible with Normal Function

Translation elongation factor isoform eEF1A2 is expressed in muscle and neurons. Deletion of eEF1A2 in mice gives rise to the neurodegenerative phenotype "wasted" (wst). Mice homozygous for the wasted mutation die of muscle wasting and neurodegeneration at four weeks post-natal. Although the mutation is said to be recessive, aged heterozygous mice have never been examined in detail; a number of other mouse models of motor neuron degeneration have recently been shown to have similar, albeit less severe, phenotypic abnormalities in the heterozygous state. We therefore examined the effects of ageing on a cohort of heterozygous +/wst mice and control mice, in order to establish whether a presumed 50% reduction in eEF1A2 expression was compatible with normal function. We evaluated the grip strength assay as a way of distinguishing between wasted and wild-type mice at 3-4 weeks, and then performed the same assay in older +/wst and wild-type mice. We also used rotarod performance and immunohistochemistry of spinal cord sections to evaluate the phenotype of aged heterozygous mice. Heterozygous mutant mice showed no deficit in neuromuscular function or signs of spinal cord pathology, in spite of the low levels of eEF1A2.     

Preparation of monospecific antibodies against isoform 2 of translation elongation factor 1A (eEF1A2)

Amino acid sequences of eukaryotic translation elongation factor isoform 1 (eEF1A1) and 2 (eEF1A2) were compared and two peptide fragments of eEF1A2 were chosen as linear antigenic determinants for generation of monospecific antipeptide antibodies. Synthesized peptides corresponded to the selected peptide fragments were conjugated to bovine serum albumin (BSA) and used for immunizations of mice. Antibodies, produced against the eEF1A2 fragment 330–343 conjugated to BSA, specifically recognized this isoform in the native and partially denatured states but did not interact with the eEF1A1 isoform. It was shown that these monospecific anti-eEF1A2 antibodies could be employed for eEF1A2 detection both by enzyme-linked immunosorbent assay and by immunoblotting.